|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Regional Oncology Research Center
|
5P30CA006973-52
|
$6,995,267
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
2P30CA068485-19
|
$5,816,049
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-41
|
$5,755,389
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Cancer Center Support Grant
|
2P30CA047904-27
|
$5,129,654
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA016058-39
|
$4,582,303
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA014599-40
|
$4,272,677
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant (CCSG)
|
2P30CA030199-34
|
$3,887,448
|
POWIS, GARTH
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Core Support for Cancer Center
|
6P30CA013330-43
|
$3,696,138
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Cancer Center Support Grant
|
5P30CA046934-27
|
$3,601,591
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant-P30
|
5P30CA093373-13
|
$3,138,579
|
DEVERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-17
|
$2,930,104
|
SELLERS, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Cancer Center Support Grant
|
5P30CA072720-18
|
$2,922,756
|
DIPAOLA, ROBERT
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Translational Research in Cancer
|
5P30CA056036-16
|
$2,807,751
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Program Project in Models of Breast Cancer
|
5P01CA094060-12
|
$2,643,408
|
NORTON, LARRY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-33
|
$2,529,146
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Stanford University Cancer Center
|
3P30CA124435-08S3
|
$2,249,153
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Mayo Clinic Breast Cancer SPORE
|
5P50CA116201-10
|
$2,185,001
|
GOETZ, MATTHEW
|
MAYO CLINIC ROCHESTER
|
|
SPORE in Breast Cancer
|
5P50CA098131-13
|
$2,185,000
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
Mayo Clinic Ovarian Cancer SPORE
|
2P50CA136393-06A1
|
$2,184,999
|
KAUFMANN, SCOTT
|
MAYO CLINIC ROCHESTER
|
|
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
|
5P50CA168504-03
|
$2,135,538
|
WINER, ERIC
|
DANA-FARBER CANCER INST
|
|
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
|
5P50CA070907-17
|
$2,041,142
|
MINNA, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Therapy & Research Center at UTHSCSA
|
5P30CA054174-21
|
$1,800,000
|
THOMPSON, IAN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
2P30CA142543-06
|
$1,615,000
|
WILLSON, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
OHSU Knight Cancer Institute
|
5P30CA069533-18
|
$1,540,000
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-29
|
$1,485,000
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Papillomavirus Virion Proteins and Vaccines
|
ZIA BC 009052
|
$1,168,210
|
Schiller, John
|
CCR (NCI)
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,042,262
|
Alter
|
DCEG (NCI)
|
|
Dermatology Consultation Clinic and Clinical Research
|
ZID BC 010688
|
$1,006,373
|
Turner, Maria
|
CCR (NCI)
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
3P50CA083639-15S1
|
$901,656
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$872,302
|
Gottesman, Michael
|
CCR (NCI)
|
|
Pharmacogenomics of Microtubule Targeting Agents
|
1R01CA192156-01A1
|
$851,184
|
KROETZ, DEANNA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Continuation of follow-up of DES-exposed cohorts
|
ZIA CP010168-00020
|
$754,820
|
Hoover
|
DCEG (NCI)
|
|
Papillomavirus Virion Proteins and Vaccines
|
ZIA BC 010579
|
$749,496
|
Lowy, Douglas
|
CCR (NCI)
|
|
Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs
|
ZIA BC 010770
|
$733,275
|
Poirier, Miriam
|
CCR (NCI)
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
ZIA SC 006353
|
$719,019
|
Brechbiel, Martin
|
CCR (NCI)
|
|
Immunogenetics of Cervical and Vulvar Cancer
|
5R01CA112512-05
|
$619,763
|
Schwartz, Stephen
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SunCoast CCOP Research Base at the University of South Florida
|
3U10CA081920-12S3
|
$590,485
|
KRISCHER, JEFFREY
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Image-guided combination therapy: noninvasive assessment of delivery and response
|
5R01CA154738-05
|
$562,844
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
|
ZIA SC 010098
|
$530,118
|
Dahut, William
|
CCR (NCI)
|
|
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)
|
5R01CA170595-04
|
$528,881
|
GATENBY, ROBERT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer
|
5R01CA158881-05
|
$523,530
|
COLEMAN, TIMOTHY
|
NEMUCORE MEDICAL INNOVATIONS, INC.
|
|
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers
|
5R01CA184968-02
|
$509,161
|
SIKIC, BRANIMIR
|
STANFORD UNIVERSITY
|
|
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer
|
5R42CA156933-03
|
$492,378
|
KOPECEK, JINDRICH
|
THERATARGET
|
|
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
|
ZIA BC 005177
|
$488,850
|
Poirier, Miriam
|
CCR (NCI)
|
|
Enhancing neoadjuvant chemotherpay responses with targeted T cells
|
5R01CA140314-06
|
$477,633
|
LUM, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
2U01CA142565-06
|
$462,917
|
YANKEELOV, THOMAS
|
VANDERBILT UNIVERSITY
|
|
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanc
|
1R01CA198096-01
|
$452,195
|
STRAUBINGER, ROBERT
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Understanding and Targeting the Glutamine Carrier SLC1A5 in Breast Cancer
|
1R01CA188372-01A1
|
$446,063
|
RONAI, ZE'EV
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|